TY - JOUR
T1 - Three-dimensional printing, holograms, computational modelling, and artificial intelligence for adult congenital heart disease care
T2 - an exciting future
AU - Chessa, Massimo
AU - Van De Bruaene, Alexander
AU - Farooqi, Kanwal
AU - Valverde, Israel
AU - Jung, Christian
AU - Votta, Emiliano
AU - Sturla, Francesco
AU - Diller, Gerhard Paul
AU - Brida, Margarita
AU - Sun, Zhonghua
AU - Little, Stephen H.
AU - Gatzoulis, Michael A.
N1 - © The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. All rights reserved. For permissions, please e-mail: [email protected].
PY - 2022/7/21
Y1 - 2022/7/21
N2 - Congenital heart disease (CHD) is often comprised of complex three-dimensional (3D) anatomy that must be well understood to assess the pathophysiological consequences and guide therapy. Thus, detailed cardiac imaging for early detection and planning of interventional and/or surgical treatment is paramount. Advanced technologies have revolutionized diagnostic and therapeutic practice in CHD, thus playing an increasing role in its management. Traditional reliance on standard imaging modalities including echocardiography, cardiac computed tomography (CT) and magnetic resonance imaging (MRI) has been augmented by the use of recent technologies such as 3D printing, virtual reality, augmented reality, computational modelling, and artificial intelligence because of insufficient information available with these standard imaging techniques. This has created potential opportunities of incorporating these technologies into routine clinical practice to achieve the best outcomes through delivery of personalized medicine. In this review, we provide an overview of these evolving technologies and a new approach enabling physicians to better understand their real-world application in adult CHD as a prelude to clinical workflow implementation.
AB - Congenital heart disease (CHD) is often comprised of complex three-dimensional (3D) anatomy that must be well understood to assess the pathophysiological consequences and guide therapy. Thus, detailed cardiac imaging for early detection and planning of interventional and/or surgical treatment is paramount. Advanced technologies have revolutionized diagnostic and therapeutic practice in CHD, thus playing an increasing role in its management. Traditional reliance on standard imaging modalities including echocardiography, cardiac computed tomography (CT) and magnetic resonance imaging (MRI) has been augmented by the use of recent technologies such as 3D printing, virtual reality, augmented reality, computational modelling, and artificial intelligence because of insufficient information available with these standard imaging techniques. This has created potential opportunities of incorporating these technologies into routine clinical practice to achieve the best outcomes through delivery of personalized medicine. In this review, we provide an overview of these evolving technologies and a new approach enabling physicians to better understand their real-world application in adult CHD as a prelude to clinical workflow implementation.
KW - 3D printing
KW - Adult with congenital heart defect
KW - Artificial intelligence
KW - Augmented reality
KW - Computational modelling
KW - Virtual reality
KW - Heart
KW - Artificial Intelligence
KW - Humans
KW - Heart Defects, Congenital/surgery
KW - Adult
KW - Printing, Three-Dimensional
KW - Virtual Reality
UR - http://www.scopus.com/inward/record.url?scp=85133806003&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133806003&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehac266
DO - 10.1093/eurheartj/ehac266
M3 - Review article
C2 - 35608227
AN - SCOPUS:85133806003
SN - 0195-668X
VL - 43
SP - 2672
EP - 2684
JO - European heart journal
JF - European heart journal
IS - 28
ER -